Literature DB >> 16897312

A novel approach incorporating sildenafil in the management of symptomatic neonates with Ebstein's anomaly.

Phat Pham1, Andrew Hoyer, Robin Shaughnessy, Yuk M Law.   

Abstract

The neonatal presentation of Ebstein's anomaly is a distinct cyanotic lesion for which little can be done other than to maintain ductal patency or perform palliative surgery if improvement does not occur. We report two cases in which sildenafil was introduced to assist previously failed attempts at weaning of prostaglandin.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16897312     DOI： 10.1007/s00246-006-1203-9

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN： 0172-0643            Impact factor:   1.655


  14 in total

1.  Diagnostic and therapeutic uses of inhaled nitric oxide in neonatal Ebstein's anomaly.

Authors:  Andrew M Atz; Ricardo A Munoz; Ian Adatia; David L Wessel
Journal:  Am J Cardiol       Date:  2003-04-01       Impact factor: 2.778

2.  A new procedure for Ebstein's anomaly.

Authors:  Qingyu Wu; Zhixiong Huang
Journal:  Ann Thorac Surg       Date:  2004-02       Impact factor: 4.330

Review 3.  Nitric oxide pathway and phosphodiesterase inhibitors in pulmonary arterial hypertension.

Authors:  Hossein A Ghofrani; Joanna Pepke-Zaba; Joan A Barbera; Richard Channick; Anne M Keogh; Miguel A Gomez-Sanchez; Meinhard Kneussl; Friedrich Grimminger
Journal:  J Am Coll Cardiol       Date:  2004-06-16       Impact factor: 24.094

Review 4.  Symptomatic neonates with Ebstein anomaly.

Authors:  Andreas Pflaumer; Andreas Eicken; Norbert Augustin; John Hess
Journal:  J Thorac Cardiovasc Surg       Date:  2004-04       Impact factor: 5.209

5.  Ebstein's anomaly: presentation and outcome from fetus to adult.

Authors:  D S Celermajer; C Bull; J A Till; S Cullen; V P Vassillikos; I D Sullivan; L Allan; P Nihoyannopoulos; J Somerville; J E Deanfield
Journal:  J Am Coll Cardiol       Date:  1994-01       Impact factor: 24.094

6.  Neonatal repair of Ebstein's anomaly: indications, surgical technique, and medium-term follow-up.

Authors:  C J Knott-Craig; E D Overholt; K E Ward; J D Razook
Journal:  Ann Thorac Surg       Date:  2000-05       Impact factor: 4.330

7.  Intravenous sildenafil is a potent pulmonary vasodilator in children with congenital heart disease.

Authors:  Ingram Schulze-Neick; Paulina Hartenstein; Jia Li; Brigitte Stiller; Nicole Nagdyman; Michael Hübler; Ghazwan Butrous; Andy Petros; Peter Lange; Andrew N Redington
Journal:  Circulation       Date:  2003-09-09       Impact factor: 29.690

8.  Ventricularization of the atrialized chamber: a concept of Ebstein's anomaly repair.

Authors:  Michael V Ullmann; Sabine Born; Christian Sebening; Matthias Gorenflo; Herbert E Ulmer; Siegfried Hagl
Journal:  Ann Thorac Surg       Date:  2004-09       Impact factor: 4.330

9.  Early and medium-term results for repair of Ebstein anomaly.

Authors:  Jonathan M Chen; Ralph S Mosca; Karen Altmann; Beth F Printz; Kimara Targoff; Pamela A Mazzeo; Jan M Quaegebeur
Journal:  J Thorac Cardiovasc Surg       Date:  2004-04       Impact factor: 5.209

10.  Inhaled nitric oxide therapy in a critically ill neonate with Ebstein's anomaly.

Authors:  E Bruckheimer; Z Bulbul; E Pinter; M Gailani; C S Kleinman; J T Fahey
Journal:  Pediatr Cardiol       Date:  1998 Nov-Dec       Impact factor: 1.655
View more
  1 in total

1.  Ebstein's anomaly of the tricuspid valve.

Authors:  Michelle Gurvitz; Karen Stout
Journal:  Curr Cardiol Rep       Date:  2007-07       Impact factor: 2.931
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.